Article preview from
Medtech Insight - June, 2010
The excise tax has been the medical device industry's main concern about pending health care reform, but other changes are taking place that will alter the market and potentially have a greater impact on sales and profits than the 2.3% tax. Specifically, device manufacturers' customers are at the beginning of changes that will alter reimbursement from the CMS to reflect adherence to standards of "best medical practices" tied to quality patient outcomes.
Continue reading "Health Care Reform: The Excise Tax Was Only the Beginning" »
Article preview from
IN VIVO - July, 2010
Medical device makers may have more difficult time selling in Europe than they'd anticipated as concerns over the economy and costs take hold, according to one analysis.
Continue reading "European Cost Concerns May Impact Devices" »
Article preview from
Start Up - July, 2010
China has become especially enticing as an unpenetrated, gigantic health care market, especially since the government in 2009 signed into effect a health care reform bill promising $125 billion over a three-year period to modernize the infrastructure of health care and provide insurance coverage to hundreds of millions of people. Medical device companies look to China as an enormous and rapidly growing market for medical disposables and equipment. However, the complex nature of the distribution infrastructure in China will make it difficult for companies to get a foothold. Headquartered in Beijing, TCT Medical Inc., which recently received $10 million in venture funding from Fidelity Asia Ventures and Fidelity Biosciences, its sister firm in the US, offers a potential solution for companies focused on women's health, and a model for the future.
Continue reading "TCT Medical Offers A New Model For Device Distribution In China" »
Article preview from
"The Silver Sheet" - July, 2010
FDA's device center wants to create a database to help officials and staff pinpoint "compliance targets" and develop detailed manufacturer risk profiles.
Continue reading "CDRH Strategic Plan Calls For Database To Identify 'Compliance Targets'" »
Article preview from
"The Gray Sheet" - July 27, 2010
FDA and the Federal Communications Commission hope to make life easier for developers of wireless medical devices by improving the efficiency of their overlapping regulatory processes, according to an agreement announced by heads of the two agencies July 26.
Continue reading "FDA, FCC Agree To Streamline Regulation Of Wireless Health Devices " »
Article preview from
"The Gray Sheet" - July 26, 2010
CDRH has been busy for the past two months in an effort to bring direct-to-consumer genetic test services into its regulatory fold, but Center Director Jeff Shuren acknowledged to a House subcommittee last week that the agency was slow to tackle the matter.
Continue reading "'We Should Have Acted Sooner' On DTC Gene Tests, Shuren Tells Lawmakers " »
Article preview from
"The Gray Sheet" -July 26, 2010
Device and drug makers say FDA's draft proposals for publicly releasing more information on product applications would cripple the industry without providing much benefit to patients.
Continue reading "Device Firms Criticize FDA Proposals To Share More Pre-Market Intel" »